- Report
- March 2024
- 187 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- November 2023
- 150 Pages
Global
From €4681EUR$4,850USD£4,016GBP
- Report
- November 2023
- 143 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- March 2024
- 196 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 199 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 197 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- August 2023
- 230 Pages
Global
From €2365EUR$2,450USD£2,028GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- April 2024
- 413 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- March 2024
- 147 Pages
Global
From €3763EUR$3,899USD£3,228GBP
- Report
- November 2023
- 138 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Drug Pipelines
- April 2024
- 250 Pages
Global
From €2896EUR$3,000USD£2,484GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Report
- April 2024
- 180 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- February 2024
- 182 Pages
Global
From €4729EUR$4,900USD£4,057GBP
The Antihypertensive market is a subset of the Cardiovascular Drugs market, which focuses on medications used to treat high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Antihypertensives work by blocking the action of certain hormones, such as angiotensin II, which cause blood vessels to constrict. Common classes of antihypertensives include diuretics, beta blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers.
The Antihypertensive market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo, also offer antihypertensive medications. Show Less Read more